Company intelligence / Profile preview

YAC Holdings

Tokyo, Tokyo, Japan

Ownership: Private
Employees: ~832
Development stage: Other

Overview

YAC Holdings has reported commercial partnerships and technological alliances in the diagnostics space. Their "NeuroDetect" platform is a highly sensitive immunoassay system used for blood marker detection, and their "SAMURAI" hair slicer system is used for hair-based disease marker analysis. They have ongoing commercial collaborations and are beginning service rollouts in Japan and globally.

Therapeutic areas: NeurologyPsychiatryOther
Modalities: DeviceImmunoassayDiagnostic
Industry: Protein Biomarker Diagnostics

Partnerships

Linus Biotechnology (strategic and capital alliance for hair-based and blood-based disease diagnostics)

Beyond the preview

Go deeper on YAC Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YAC Holdings.

Explore the full profile